ClearBridge Emerging Markets I (MCEIX)
Nasdaq • Currently up 0.39 (+2.25%) in today's trading session
1 member of Congress has disclosed 1 trade in ClearBridge Emerging Markets I (MCEIX) via STOCK Act filings. The most recent disclosure was a sale by Chris Coons on 4 May 2023. Aggregate disclosed activity totals roughly $8K in sales (midpoint estimates from bracketed disclosure amounts).
ClearBridge Emerging Markets I is currently trading at $17.74, positioned at 26% of its 52-week range ($16.08 – $22.51).
Want to automatically copy Pelosi trades?
Mirror Nancy Pelosi's portfolio with just one click on eToro.
Copy Trading does not amount to investment advice. The value of your investments may go up or down. Your capital is at risk.
Past Performance is not an indication of future results.
ClearBridge Emerging Markets I Price History and Technical Analysis
Congressional Trading Activity for MCEIX
| Chris Coons | 4 May 2023 | 12 Aug 2024 | Sale | Stock | $1,001 - $15,000 | N/A |
Select transactions to view their annotations on the chart
Similar Stocks
Based on congressional trading patterns
Frequently Asked Questions about MCEIX
- Which members of Congress have traded MCEIX?
- 1 member of Congress has disclosed 1 trade in ClearBridge Emerging Markets I (MCEIX) under the STOCK Act: Chris Coons.
- When was MCEIX most recently disclosed by Congress?
- The most recent MCEIX disclosure was a sale by Chris Coons on 4 May 2023.
- What is the total disclosed congressional trading volume for MCEIX?
- Members of Congress have disclosed approximately $8K in MCEIX sales (midpoint estimate derived from the bracketed amount ranges used in STOCK Act filings).
- How can I track new congressional trades in MCEIX?
- This MCEIX page updates as soon as new STOCK Act disclosures are filed for ClearBridge Emerging Markets I. Every trade, politician, transaction date and amount range is surfaced above, typically within hours of the official filing appearing on the House or Senate disclosure portals.
Track MCEIX in Congress
See when politicians buy or sell this stock